1982
DOI: 10.1111/j.1423-0410.1982.tb01097.x
|View full text |Cite
|
Sign up to set email alerts
|

A Case Study

Abstract: Both 51Cr-survival studies with donor platelets and allogenic skin transplantations were performed in a patient with immune unresponsiveness to platelet antigens, i.e., HLA-and platelet-specific antigens. The patients, who suffered from hypoplastic anaemia, was successfully transfused with random donor platelets during 13 months. The serum of this patient contained only granulocyte-and mononuclear-cell-reactive antibodies, but no platelet-reactive antibodies. A nearly normal survival time of the donor platelet… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

1985
1985
2018
2018

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(2 citation statements)
references
References 9 publications
0
2
0
Order By: Relevance
“…Additionally, he showed a markedly prolonged survival of an experimental skin graft from an HLA-incompatible donor. It was argued that the HNA-5a alloantibody might have blocked leukocyte interactions in the graft [100,102]. The first case of NIN caused by an HNA-5a alloantibody was described in 2011 [103].…”
Section: Hna-5mentioning
confidence: 99%
“…Additionally, he showed a markedly prolonged survival of an experimental skin graft from an HLA-incompatible donor. It was argued that the HNA-5a alloantibody might have blocked leukocyte interactions in the graft [100,102]. The first case of NIN caused by an HNA-5a alloantibody was described in 2011 [103].…”
Section: Hna-5mentioning
confidence: 99%
“…[ 11 ] In addition, a multitransfused patient with aplastic anemia who produced only anti-HNA-5a had prolonged survival of a skin graft from human leukocyte antigen (HLA) unidentical donor, because the leukocyte interactions in the graft had been blocked. [ 12 ]…”
Section: Introductionmentioning
confidence: 99%